A detailed history of Ballentine Partners, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Ballentine Partners, LLC holds 6,467 shares of TECH stock, worth $498,153. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,467
Previous 6,414 0.83%
Holding current value
$498,153
Previous $512,000 9.18%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 16, 2025

BUY
$66.37 - $78.17 $3,517 - $4,143
53 Added 0.83%
6,467 $465,000
Q3 2024

Oct 23, 2024

BUY
$70.96 - $82.35 $141 - $164
2 Added 0.03%
6,414 $512,000
Q2 2024

Aug 06, 2024

BUY
$62.12 - $84.15 $4,348 - $5,890
70 Added 1.1%
6,412 $459,000
Q1 2024

Apr 11, 2024

BUY
$65.98 - $77.09 $4,354 - $5,087
66 Added 1.05%
6,342 $446,000
Q4 2023

Jan 23, 2024

BUY
$52.83 - $78.22 $331,561 - $490,908
6,276 New
6,276 $484,000
Q2 2023

Jul 26, 2023

BUY
$73.76 - $85.98 $202,102 - $235,585
2,740 New
2,740 $223,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $3.02B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Ballentine Partners, LLC Portfolio

Follow Ballentine Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballentine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ballentine Partners, LLC with notifications on news.